Full Press Release Details
SAN FRANCISCO , June 6, 2017 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR ) announced today that its corporate presentation will be webcast at the upcoming Jefferies 2017 Global Healthcare Conference in New York City on Wednesday, June 7, 2017 at 9:30 a.m. Eastern time .
The presentation will be accessible via a Webcast through a link posted on the Investors, Events Calendar section of the Nektar website: http://ir.nektar.com/events.cfm . This Webcast will be available for replay until July 10, 2017 .
Nektar Therapeutics is a research-based development stage biopharmaceutical company whose mission is to discover and develop innovative medicines to address the unmet medical needs of patients. Our R&D pipeline of new investigational medicines includes treatments for cancer, auto-immune disease and chronic pain. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new therapeutic candidates. Nektar is headquartered in San Francisco, California , with additional operations in Huntsville, Alabama and Hyderabad, India . Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com .
Investors Jennifer Ruddock of Nektar Therapeutics 415-482-5585
SOURCE Nektar Therapeutics